Rhythm Pharmaceuticals (NASDAQ:RYTM) will release its quarterly earnings report on Tuesday, 2024-11-05. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Rhythm Pharmaceuticals to report an earnings per share (EPS) of $-0.81. The announcement from Rhythm Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Past Earnings PerformanceThe company’s EPS beat by $0.16 in the last qua…